Business Description
Virios Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US92829J1043
Share Class Description:
VIRI: Ordinary SharesDescription
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 47.7 | |||||
| 3-Year EPS without NRI Growth Rate | 48.9 | |||||
| 3-Year FCF Growth Rate | 31.1 | |||||
| 3-Year Book Growth Rate | -62 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.89 | |||||
| 9-Day RSI | 56.61 | |||||
| 14-Day RSI | 54.48 | |||||
| 6-1 Month Momentum % | -16.52 | |||||
| 12-1 Month Momentum % | -44.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.6 | |||||
| Quick Ratio | 11.6 | |||||
| Cash Ratio | 9.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -32.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -99.71 | |||||
| ROA % | -89.71 | |||||
| ROIC % | -1442.27 | |||||
| ROC (Joel Greenblatt) % | -1427.52 | |||||
| ROCE % | -102.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.37 | |||||
| Price-to-Tangible-Book | 2.35 | |||||
| EV-to-EBIT | -1.05 | |||||
| EV-to-EBITDA | -1.05 | |||||
| EV-to-FCF | -1.18 | |||||
| Price-to-Net-Current-Asset-Value | 2.35 | |||||
| Price-to-Net-Cash | 3.13 | |||||
| Earnings Yield (Greenblatt) % | -95.24 | |||||
| FCF Yield % | -53.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VIRI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virios Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.28 | ||
| Beta | 1.94 | ||
| Volatility % | 191.24 | ||
| 14-Day RSI | 54.48 | ||
| 14-Day ATR ($) | 0.054101 | ||
| 20-Day SMA ($) | 0.469485 | ||
| 12-1 Month Momentum % | -44.52 | ||
| 52-Week Range ($) | 0.279 - 2.42 | ||
| Shares Outstanding (Mil) | 19.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Virios Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Virios Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Virios Therapeutics Inc Frequently Asked Questions
What is Virios Therapeutics Inc(VIRI)'s stock price today?
The current price of VIRI is $0.47. The 52 week high of VIRI is $2.42 and 52 week low is $0.28.
When is next earnings date of Virios Therapeutics Inc(VIRI)?
The next earnings date of Virios Therapeutics Inc(VIRI) is 2024-05-10 Est..
Does Virios Therapeutics Inc(VIRI) pay dividends? If so, how much?
Virios Therapeutics Inc(VIRI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers